84 filings
Page 3 of 5
6-K
5fj2lxsg6 ya8nme8e
19 Jan 23
MDxHealth Provides Updated and Supplemental Financial Information
8:15pm
6-K
1hhqil
9 Jan 23
MDxHealth Reports Preliminary 2022 Revenues
4:01pm
EFFECT
ps97tf1
3 Jan 23
Notice of effectiveness
12:15am
CORRESP
sx8xn
28 Dec 22
Correspondence with SEC
12:00am
UPLOAD
t9tqur7 ie7
27 Dec 22
Letter from SEC
12:00am
F-3
acww4tx5len
19 Dec 22
Shelf registration (foreign)
5:01pm
6-K
qxk4eedw
19 Dec 22
Report of Independent Auditors
4:44pm
6-K
jyrhqt
29 Nov 22
MDxHealth Provides Business Update
5:26pm
6-K
dg6yqu
27 Oct 22
MDxHealth Reports Q3-2022 Results
4:00pm
6-K
9cf1mz3
26 Aug 22
Report of Foreign Private Issuer
4:00pm
6-K
v6ow4opnt bhmk3e
25 Aug 22
MDxHealth Reports Half Year 2022 Results
4:16pm
6-K
kp1vkv1w 21
19 Aug 22
Report of Foreign Private Issuer
4:22pm
D
9vz ztmdjmwo8
15 Aug 22
Indefinite amount in equity, sold $5M, 1 investor
8:50am
6-K
pgm24l
2 Aug 22
Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business
4:14pm
6-K
yp9yapnf
27 May 22
MDxHealth Announces Results of its Annual and Extraordinary
4:00pm
6-K
gal5eupw
20 May 22
Palmetto GBA’s MolDX Issues Foundational LCD Covering the Indication for SelectMDx® for Prostate Cancer
8:11am
6-K
8dr em4nj
6 May 22
Report of Foreign Private Issuer
4:02pm
6-K
b7ux2ooefmz
28 Apr 22
Report of Foreign Private Issuer
4:01pm
6-K
2mswt0
27 Apr 22
MDxHealth Reports Q1-2022 Results
4:00pm
20-F
xqtha3
25 Apr 22
Annual report (foreign)
4:01pm